Skip to main content

Table 4 Late urinary, rectal, and sexual function-related toxicities on LENT/SOMA scales after neoadjuvant chemoradiation

From: A phase II trial of neoadjuvant IMRT-based chemoradiotherapy followed by one cycle of capecitabine for stage II/III rectal adenocarcinoma

LENT/SOMA grade Urinary function Rectal function Sexual function
Num % Num % Num %
0 22 75.86 26 89.66 24 82.76
1 5 17.24 2 6.90 5 17.24
2 2 6.90 1 3.45 0 0.00
3 0 0.00 0 0.00 0 0.00
4 0 0.00 0 0.00 0 0.00
  1. LENT/SOMA Late Effects on Normal Tissue / Subjective, Objective, Management and Analytic.